BB Good human data, but mixed outcomes or surrogate markers. How we grade →RCT long-term follow-up · 3,234 adults, median 21 years, 453 deaths
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
C Lee, B Heckman-Stoddard, D Dabelea, K Gadde, D Ehrmann, L Ford et al. Diabetes Care. 2021.
- In plain language
- Metformin prevented diabetes but did not change deaths from all causes (HR 0.99), cancer (1.04) or cardiovascular disease (1.08) over a median 21 years.
- Limits
- After 2001 metformin continued unmasked and everyone was offered lifestyle support.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Metformin as an aging drug: what the evidence shows, and why the TAME trial has not started
- Source
- doi.org/10.2337/dc21-1046 · PubMed 34697033 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.